MERGED SCAFFOLD TAF1 INHIBITORS

Disclosed are inhibitors for TAF1. Methods of using the disclosed compounds to treat cancer are also disclosed. L'invention concerne des inhibiteurs de TAF1. Des méthodes d'utilisation des composés de la présente invention pour traiter le cancer sont également divulguées.

Saved in:
Bibliographic Details
Main Authors CHEN, Jiandong, SHULTZ, Zachary, LOPCHUK, Justin, SCHONBRUNN, Ernst, KARIM, Md Rezaul
Format Patent
LanguageEnglish
French
Published 02.06.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed are inhibitors for TAF1. Methods of using the disclosed compounds to treat cancer are also disclosed. L'invention concerne des inhibiteurs de TAF1. Des méthodes d'utilisation des composés de la présente invention pour traiter le cancer sont également divulguées.
Bibliography:Application Number: WO2021US61121